232 related articles for article (PubMed ID: 22344874)
1. Molecular imaging: challenges of bringing imaging of intracellular targets into common clinical use.
Skotland T
Contrast Media Mol Imaging; 2012; 7(1):1-6. PubMed ID: 22344874
[TBL] [Abstract][Full Text] [Related]
2. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
Vallabhajosula S
Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
[TBL] [Abstract][Full Text] [Related]
3. [New challenges and perspectives in nuclear medicine imaging].
Borbély K
Magy Onkol; 2014 Dec; 58(4):232-8. PubMed ID: 25517440
[TBL] [Abstract][Full Text] [Related]
4. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
[TBL] [Abstract][Full Text] [Related]
5. Optimization of the reference region method for dual pharmacokinetic modeling using Gd-DTPA/MRI and (18) F-FDG/PET.
Poulin É; Lebel R; Croteau É; Blanchette M; Tremblay L; Lecomte R; Bentourkia M; Lepage M
Magn Reson Med; 2015 Feb; 73(2):740-8. PubMed ID: 24604379
[TBL] [Abstract][Full Text] [Related]
6. Optimizing positron emission tomography image acquisition protocols in integrated positron emission tomography/magnetic resonance imaging.
Hartung-Knemeyer V; Beiderwellen KJ; Buchbender C; Kuehl H; Lauenstein TC; Bockisch A; Poeppel TD
Invest Radiol; 2013 May; 48(5):290-4. PubMed ID: 23399811
[TBL] [Abstract][Full Text] [Related]
7. Clinical molecular imaging with PET agents other than 18F-FDG.
Hall LT; Struck AF; Perlman SB
Curr Pharm Biotechnol; 2010 Sep; 11(6):545-54. PubMed ID: 20420567
[TBL] [Abstract][Full Text] [Related]
8. Combined imaging modalities: PET/CT and SPECT/CT.
Maurer AH
Health Phys; 2008 Nov; 95(5):571-6. PubMed ID: 18849691
[TBL] [Abstract][Full Text] [Related]
9. Characterizing the inflammatory tissue response to acute myocardial infarction by clinical multimodality noninvasive imaging.
Wollenweber T; Roentgen P; Schäfer A; Schatka I; Zwadlo C; Brunkhorst T; Berding G; Bauersachs J; Bengel FM
Circ Cardiovasc Imaging; 2014 Sep; 7(5):811-8. PubMed ID: 25049056
[TBL] [Abstract][Full Text] [Related]
10. Small-animal molecular imaging methods.
de Kemp RA; Epstein FH; Catana C; Tsui BM; Ritman EL
J Nucl Med; 2010 May; 51 Suppl 1(0 1):18S-32S. PubMed ID: 20457793
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
12. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
13. Molecular imaging of breast cancer.
Oude Munnink TH; Nagengast WB; Brouwers AH; Schröder CP; Hospers GA; Lub-de Hooge MN; van der Wall E; van Diest PJ; de Vries EG
Breast; 2009 Oct; 18 Suppl 3():S66-73. PubMed ID: 19914546
[TBL] [Abstract][Full Text] [Related]
14. SPECT and PET radiopharmaceuticals for molecular imaging of apoptosis: from bench to clinic.
Wang X; Feng H; Zhao S; Xu J; Wu X; Cui J; Zhang Y; Qin Y; Liu Z; Gao T; Gao Y; Zeng W
Oncotarget; 2017 Mar; 8(12):20476-20495. PubMed ID: 28108738
[TBL] [Abstract][Full Text] [Related]
15. A realistic utilization of nanotechnology in molecular imaging and targeted radiotherapy of solid tumors.
Patel V; Papineni RV; Gupta S; Stoyanova R; Ahmed MM
Radiat Res; 2012 Apr; 177(4):483-95. PubMed ID: 22404738
[TBL] [Abstract][Full Text] [Related]
16. PET/MRI: challenges, solutions and perspectives.
Herzog H
Z Med Phys; 2012 Dec; 22(4):281-98. PubMed ID: 22925652
[TBL] [Abstract][Full Text] [Related]
17. Is there a role for PET-CT and SPECT-CT in pediatric oncology?
Biermann M; Schwarzlmüller T; Fasmer KE; Reitan BC; Johnsen B; Rosendahl K
Acta Radiol; 2013 Nov; 54(9):1037-45. PubMed ID: 23319723
[TBL] [Abstract][Full Text] [Related]
18. Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies.
Nanni C; Pettinato C; Ambrosini V; Spinelli A; Trespidi S; Rubello D; Al-Nahhas A; Franchi R; Alavi A; Fanti S
Nucl Med Commun; 2007 Jul; 28(7):547-53. PubMed ID: 17538396
[TBL] [Abstract][Full Text] [Related]
19. The pivotal role of FDG-PET/CT in modern medicine.
Hess S; Blomberg BA; Zhu HJ; Høilund-Carlsen PF; Alavi A
Acad Radiol; 2014 Feb; 21(2):232-49. PubMed ID: 24439337
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography.
Sandler MP; Videlefsky S; Delbeke D; Patton JA; Meyerowitz C; Martin WH; Ohana I
J Am Coll Cardiol; 1995 Oct; 26(4):870-8. PubMed ID: 7560611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
